EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Investigation of Lysosome‐Associated Membrane Protein 3 Highlighting the Role of Lysosome in Pathophysiology and Treatment of Sjögren Disease

Hiroyuki Nakamura iD, Tsutomu Tanaka iD, Masayuki Noguchi, Tatsuya Atsumi, Blake M Warner iD, John A Chiorini

Arthritis & Rheumatology · 2026-04 · 78 (4) · 791-800

DOI: 10.1002/art.43347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arthritis & Rheumatology, online erschienen am 30.11.2025. Verfasst von Hiroyuki Nakamura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University and Department of …. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Lysosomes, Lysosomal Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: NIH HHS, Japan Society for the Promotion of Science, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysosome‐associated membrane protein 3 (LAMP3) is a unique lysosomal membrane protein specifically expressed in mature dendritic cells and type II pneumocytes. Its ectopic expression in salivary gland epithelial cells (SGECs) is induced by type I interferon (IFN) signaling and is further amplified through Toll‐like receptor 7 (TLR7) activation, which is implicated in the pathogenesis of Sjögren disease (SjD). This aberrant up‐regulation disrupts glandular function by promoting endolysosomal degradation of aquaporin 5 (AQP5) and sodium–potassium–chloride cotransporter 1, leading to impaired fluid secretion and associated clinical sequelae (eg, dry mouth). Additionally, LAMP3‐mediated lysosomal exocytosis of DAMPs enhances monocytic bone morphogenetic protein 6 (BMP6) production, which in turn suppresses AQP5 transcription. Moreover, LAMP3 drives the extracellular vesicle–mediated release of autoantigens, which further amplifies autoimmunity, and lysosome‐dependent cell death in SGECs contributes to tissue damage. These findings establish LAMP3 as a pivotal regulatory hinge in SjD pathogenesis, linking IFN/TLR7 signaling, lysosomal dysfunction, and glandular hypofunction. Its central role makes it a compelling therapeutic target, with strategies including IFN and TLR7 pathway inhibitors to limit its induction, restoration of lysosomal function, BMP6 inhibition to preserve AQP5 expression, and AQP gene therapy to improve fluid secretion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeLysosomesLysosomal Membrane ProteinsHumansSalivary GlandsToll-Like Receptor 7Signal TransductionAquaporin 5Interferon Type IEpithelial CellsNeoplasm ProteinsLysosomal-Associated Membrane Protein 3

Substanzen

Lysosomal Membrane ProteinsToll-Like Receptor 7LAMP3 protein, humanAquaporin 5Interferon Type INeoplasm ProteinsLysosomal-Associated Membrane Protein 3

Autor:innen und Institutionen

  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University and Department of Rheumatology and Clinical Immunology, Sapporo Medical University Schoo…
  • Department of Immunology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Division of Cancer Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan, and Department of Pulmonary Medicine, Gengendo Kimitsu Hospital, Chiba, Japan.
  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland.

ORCID-Profile: Hiroyuki Nakamura, Tsutomu Tanaka, Blake M Warner

Förderung

  • NIH HHS
  • Japan Society for the Promotion of Science
  • NIDCR NIH HHS
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Nakamura, H., Tanaka, T., Noguchi, M., Atsumi, T., Warner, B. M., & Chiorini, J. A. (2026). Investigation of Lysosome‐Associated Membrane Protein 3 Highlighting the Role of Lysosome in Pathophysiology and Treatment of Sjögren Disease. Arthritis & Rheumatology, 78(4), 791-800. https://doi.org/10.1002/art.43347

Vancouver

Nakamura H, Tanaka T, Noguchi M, Atsumi T, Warner BM, Chiorini JA. Investigation of Lysosome‐Associated Membrane Protein 3 Highlighting the Role of Lysosome in Pathophysiology and Treatment of Sjögren Disease. Arthritis & Rheumatology. 2026;78(4):791-800. doi:10.1002/art.43347

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Hiroyuki and Tanaka, Tsutomu and Noguchi, Masayuki and Atsumi, Tatsuya and Warner, Blake M and Chiorini, John A},
  title = {Investigation of Lysosome‐Associated Membrane Protein 3 Highlighting the Role of Lysosome in Pathophysiology and Treatment of Sjögren Disease},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  volume = {78},
  number = {4},
  pages = {791--800},
  doi = {10.1002/art.43347}
}
Kostenlos starten →